Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | LXFR | Ordinary Shares | Options Exercise | +750 | +4.05% | 19.3K | Mar 20, 2024 | Direct | F1, F2 | ||
transaction | LXFR | Ordinary Shares | Options Exercise | +127 | +0.66% | 19.4K | Mar 20, 2024 | Direct | F1 | ||
transaction | LXFR | Ordinary Shares | Options Exercise | +1K | +5.16% | 20.4K | Mar 20, 2024 | Direct | F1 | ||
transaction | LXFR | Ordinary Shares | Options Exercise | +78 | +0.38% | 20.5K | Mar 20, 2024 | Direct | F1 | ||
transaction | LXFR | Ordinary Shares | Options Exercise | +800 | +3.91% | 21.3K | Mar 20, 2024 | Direct | F1 | ||
transaction | LXFR | Ordinary Shares | Options Exercise | +87 | +0.41% | 21.4K | Mar 20, 2024 | Direct | F1 | ||
transaction | LXFR | Ordinary Shares | Options Exercise | +1.07K | +5.01% | 22.4K | Mar 20, 2024 | Direct | F1 | ||
transaction | LXFR | Ordinary Shares | Options Exercise | +51 | +0.23% | 22.5K | Mar 20, 2024 | Direct | F1 | ||
transaction | LXFR | Ordinary Shares | Tax liability | -$21.8K | -2.04K | -9.09% | $10.67 | 20.4K | Mar 20, 2024 | Direct |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | LXFR | Stock Options (Right to Buy) | Options Exercise | -750 | -100% | 0 | Mar 20, 2024 | Ordinary Shares | 750 | Direct | F1, F3 | |||
transaction | LXFR | Dividend Equivalent Rights | Options Exercise | -127 | -100% | 0 | Mar 20, 2024 | Ordinary Shares | 127 | Direct | F4 | |||
transaction | LXFR | Stock Options (Right to Buy) | Options Exercise | -1K | -33.33% | 2K | Mar 20, 2024 | Ordinary Shares | 1K | Direct | F1, F5 | |||
transaction | LXFR | Dividend Equivalent Rights | Options Exercise | -78 | -32.1% | 165 | Mar 20, 2024 | Ordinary Shares | 78 | Direct | F4 | |||
transaction | LXFR | Stock Options (Right to Buy) | Options Exercise | -800 | -50% | 800 | Mar 20, 2024 | Ordinary Shares | 800 | Direct | F1, F6 | |||
transaction | LXFR | Dividend Equivalent Rights | Options Exercise | -87 | -48.6% | 92 | Mar 20, 2024 | Ordinary Shares | 87 | Direct | F4 | |||
transaction | LXFR | Stock Options (Right to Buy) | Options Exercise | -1.07K | -25% | 3.21K | Mar 20, 2024 | Ordinary Shares | 1.07K | Direct | F1, F7 | |||
transaction | LXFR | Dividend Equivalent Rights | Options Exercise | -51 | -24.17% | 160 | Mar 20, 2024 | Ordinary Shares | 51 | Direct | F4 |
Id | Content |
---|---|
F1 | 1 for 1, subject to a nominal payment of $1.00 per Ordinary Share. |
F2 | The above figure includes (i) 231 Ordinary Shares, including those accrued related to dividend reinvestment rights, acquired pursuant to the Luxfer Holdings PLC Share Incentive Plan for the purchase period of June 1, 2023 - December 31, 2023; and (ii) 255 Ordinary Shares acquired since the Reporting Person's last reportable transaction pursuant to dividend reinvestment transactions. |
F3 | Represents the exercise of time-based Stock Options awarded on March 13, 2020. The subject Stock Options fully vested and were exercisable as of March 13, 2024. |
F4 | Represents dividend equivalent rights accrued on employee Stock Options, which become exercisable proportionately with the Stock Options to which they relate. Each dividend equivalent right is the economic equivalent of one Ordinary Share. The subject dividend equivalent rights convert 1 for 1, subject to a nominal payment of $1.00 per Ordinary Share. |
F5 | Represents the exercise of time-based Stock Options awarded on March 14, 2022. The subject Stock Options vested and were exercisable as of March 14, 2024. The remaining Stock Options vest and become exercisable in two equal annual installments on March 14, 2025 and March 14, 2026. |
F6 | Represents the exercise of time-based Stock Options awarded on March 15, 2021. The subject Stock Options vested and were exercisable as of March 15, 2024. The remaining Stock Options vest and become exercisable on March 15, 2025. |
F7 | Represents the exercise of time-based Stock Options awarded on March 20, 2023. The subject Stock Options vested and were exercisable as of March 20, 2024. The remaining Stock Options vest in three equal annual installments beginning on March 20, 2025. |